KDA Group (TSXV:KDA) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


What is KDA Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

KDA Group's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TSXV:KDA vs VEEV, BTSG, TEM: Margin of Safety % (DCF Earnings Based) Comparison

For the Health Information Services subindustry, KDA Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KDA Group Margin of Safety % (DCF Earnings Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, KDA Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where KDA Group's Margin of Safety % (DCF Earnings Based) falls into.


KDA Group Business Description

Other Exchanges KDAGF:USAO1M:Germany
Address 1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.